Follow the Tilray Brands, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Tilray Brands, Inc. has published 128 public disclosures. Market capitalisation: €546.3m. The latest transaction was reported on 7 August 2026 (Acquisition). Among the most active insiders: Merton Carl A. Every trade is accessible without an account.
128
Insider Decl.
n/a
Thresholds
€365,724
11 ops.
Buy Volume
€6m
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Tilray Brands, Inc. Buy (bullish), based on 8 analysts. Average price target: US$7.84.
39Σ signal
Buys €365,724€6m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,879 of 28,900 companies
22.3
score / 100
Value
25
Quality
20
FCF yld-3.5%
Earn yld-4.4%
EV/EBITDA·
ROE-40%
Gross mgn28%
Net mgn-14%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Tilray Brands, Inc. is a company focused on the production and distribution of cannabis-based products. It primarily operates in the U.S. and Canadian markets.